Showing results (321-330 of 380) with videos related to
Sort By:
Pageof 38
BMJ (Clinical Research Ed.)|August 2, 2015
Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort studyOlivier Aubert, Nassim Kamar, Dewi Vernerey, et al.Transplantation|November 12, 2015
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled TrialBénédicte Sautenet, Gilles Blancho, Mathias Büchler, et al.BJU International|June 11, 2021
Kidney transplantation from expanded criteria donors: an increased risk of urinary complications - the UriNary Complications Of Renal Transplant (UNyCORT) studyBenoit Mesnard, Maxime Leroy, James Hunter, et al.Kidney International|April 9, 2019
Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppressionRenaud Snanoudj, Nassim Kamar, Elisabeth Cassuto, et al.The Lancet. Diabetes & Endocrinology|May 20, 2018
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trialSandrine Lablanche, Marie-Christine Vantyghem, Laurence Kessler, et al.Anaerobe|March 11, 2017
Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohortNagham Khanafer, Philippe Vanhems, Frédéric Barbut, et al.The New England Journal of Medicine|December 14, 2007
Outcomes 18 months after the first human partial face transplantationJean-Michel Dubernard, Benoit Lengelé, Emmanuel Morelon, et al.The Journal of Clinical Investigation|May 28, 2025
Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejectionThomas Barba, Martin Oberbarnscheidt, Gregory Franck, et al.Journal of Hepatology|November 25, 2019
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver diseaseAmine Majdi, Lynda Aoudjehane, Vlad Ratziu, et al.JHEP Reports : Innovation in Hepatology|March 11, 2026
Long-term outcomes and temporal trends following liver transplantation for chronic liver disease in the intensive care unitMagdalena Meszaros, José Ursic-Bedoya, Audrey Coilly, et al.Pageof 38